Hiroshi Nanjyo

Akita, 0108543, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Molecular pathology provides significant insights into the diagnosis and treatment of cancer of unknown primary origin: a case report of an extremely rare male occult breast apocrine cancer.

Molecular pathology provides significant insights into the diagnosis and treatment of cancer of unknown primary origin: a case report of an extremely rare male occult breast apocrine cancer.

Journal: International cancer conference journal

Published: November 10, 2025

Role of clonal lineage analysis via next-generation sequencing in identifying the origin of multiple cancers and guiding treatment options.

Role of clonal lineage analysis via next-generation sequencing in identifying the origin of multiple cancers and guiding treatment options.

Journal: Japanese journal of clinical oncology

Published: August 28, 2025

PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab.

PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab.

Journal: International cancer conference journal

Published: November 19, 2023

Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor.

Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor.

Journal: Japanese journal of clinical oncology

Published: August 02, 2023

Soft Tissue Tumor Without Neurofibromatosis Type 1 With Histopathological Suspicion of Atypical Neurofibromatous Neoplasm of Uncertain Biological Potential (ANNUBP).

Soft Tissue Tumor Without Neurofibromatosis Type 1 With Histopathological Suspicion of Atypical Neurofibromatous Neoplasm of Uncertain Biological Potential (ANNUBP).

Journal: Cureus

Published: April 25, 2023

Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor.

Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor.

Journal: Case reports in oncology

Published: September 01, 2022

Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A > T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab.

Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A > T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab.

Journal: Japanese journal of clinical oncology

Published: June 29, 2022

Soft tissue round cell sarcoma of the abdominal wall, with EWSR1-non-ETS fusion (EWSR1-NFATC2 sarcoma): A case report and literature review emphasizing its clinical features.

Soft tissue round cell sarcoma of the abdominal wall, with EWSR1-non-ETS fusion (EWSR1-NFATC2 sarcoma): A case report and literature review emphasizing its clinical features.

Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association

Published: October 26, 2021

Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry.

Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry.

Journal: Case reports in oncology

Published: October 18, 2021

Sudden and severe cardiotoxicity induced with pembrolizumab, its clinical course, therapeutic intervention, and outcome.

Sudden and severe cardiotoxicity induced with pembrolizumab, its clinical course, therapeutic intervention, and outcome.

Journal: International cancer conference journal

Published: September 11, 2021

A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val).

A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val).

Journal: Japanese journal of clinical oncology

Published: September 11, 2021

First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology.

First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology.

Journal: Scientific reports

Published: August 03, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026